Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NMRA Neumora Therapeutics, Inc.

休市中 11-13 16:00:00 EST

0.4289

-0.0041

-0.95%

盘后0.4590

+0.0301+7.02%

19:51 EST

最高0.4862	最低0.4207	成交量56.93万
今开0.4368	昨收0.4330	日振幅15.12%
总市值8,063万	流通市值4,975万	总股本1.88亿
成交额24.95万	换手率0.49%	流通股本1.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":0.4289,"timestamp":1794603600000,"preClose":0.433,"halted":0,"volume":569287,"hourTrading":{"tag":"盘后","latestPrice":0.459,"preClose":0.4289,"latestTime":"19:51 EST","volume":15937,"amount":7273.5157,"timestamp":1794617477798,"change":0.0301,"changeRate":0.07018,"amplitude":0.07018},"delay":0,"changeRate":-0.009468822170900676,"floatShares":115999999,"shares":188000000,"eps":-1.223678,"marketStatus":"休市中","change":-0.0041,"latestTime":"11-13 16:00:00 EST","open":0.4368,"high":0.48619,"low":0.4207,"amount":249464.614778,"amplitude":0.151247,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.223678,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":0.433,"preHourTrading":{"tag":"盘前","latestPrice":0.4325,"preClose":0.433,"latestTime":"08:40 EST","volume":278,"amount":122.559997,"timestamp":1794577258099,"change":-0.0005,"changeRate":-0.001155,"amplitude":0.035797},"postHourTrading":{"tag":"盘后","latestPrice":0.459,"preClose":0.4289,"latestTime":"19:51 EST","volume":15937,"amount":7273.5157,"timestamp":1794617477798,"change":0.0301,"changeRate":0.07018,"amplitude":0.07018},"volumeRatio":0.7426267854154233,"impliedVol":0.7239,"impliedVolPercentile":0.2112},"requestUrl":"/m/hq/s/NMRA","defaultTab":"news","newsList":[{"id":"1186445644","title":"Neumora Therapeutics重复13周大鼠毒理学研究显示：未发现意外的活体不良结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1186445644","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186445644?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:03","pubTimestamp":1785150209,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics公司（简称：Neumora Therapeutics, Inc.）近日宣布，其重复进行的13周大鼠毒理学研究取得了积极结果。该研究明确指出，在活体实验过程中，未观察到任何意料之外的不良反应或有害发现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167448607","title":"Neumora Therapeutics披露Nmra-215毒理学积极结果，计划2026年推进临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1167448607","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167448607?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:01","pubTimestamp":1785150114,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics公布了其候选药物Nmra-215的毒理学研究结果，表现良好。公司计划于2026年将该药物推向临床开发的下一阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119005478","title":"Neumora Therapeutics 公布 Koastal 三期项目数据并更新业务及研发管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1119005478","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119005478?lang=zh_cn&edition=full","pubTime":"2026-06-15 20:01","pubTimestamp":1781524915,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics 公司宣布了其 Koastal 三期临床试验项目的数据结果，同时提供了最新的业务进展与研发管线更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177311422","title":"Neumora Therapeutics宣布因三期临床失败而终止Navacaprant研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1177311422","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177311422?lang=zh_cn&edition=full","pubTime":"2026-06-15 20:01","pubTimestamp":1781524909,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics公司已决定终止其核心候选药物Navacaprant的后续开发工作。这一决定源于该药物在两项关键的三期临床试验——Koastal-2与Koastal-3中未能达到预设的主要疗效终点。两项试验的数据均显示，Navacaprant在治疗重度抑郁症方面，其疗效与安慰剂相比未显示出具有统计学意义的显著优势。此次研发挫折无疑对Neumora Therapeutics构成了重大打击。Navacaprant曾被公司寄予厚望，视为其产品管线中极具潜力的重磅资产。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518276710","title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518276710?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:55","pubTimestamp":1741618521,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时55分，Neumora Therapeutics, Inc.股票出现异动，股价大幅下跌5.37%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022552198a2b17c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022552198a2b17c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518210334","title":"Neumora Therapeutics, Inc.2024财年实现净利润-2.44亿美元，同比减少3.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518210334","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518210334?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449669,"startTime":"0","endTime":"0","summary":"3月9日，Neumora Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-2.44亿美元，同比减少3.39%；其中营业收入为0.00美元，每股基本收益为-1.53美元。从资产负债表来看，Neumora Therapeutics, Inc.总负债29.91百万美元，其中短期债务1.85百万美元，资产负债比为0.11，流动比率为0.11。机构评级：截至2025年3月9日，当前有6家机构对Neumora Therapeutics, Inc.目标价做出预测，其中目标均价为6.67美元，其中最低目标价为2.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000231a266b3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000231a266b3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517727458","title":"Stifel：下调Neumora Therapeutics(NMRA.US)评级，由买入调整至持有评级, 目标价由6.00美元调整至2.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517727458","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517727458?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:44","pubTimestamp":1741365844,"startTime":"0","endTime":"0","summary":"Stifel：下调Neumora Therapeutics(NMRA.US)评级，由买入调整至持有评级, 目标价由6.00美元调整至2.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08004448604766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NMRA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516162054","title":"HC Wainwright & Co.：维持Neumora Therapeutics(NMRA.US)评级，由买入调整至买入评级, 目标价由30.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516162054","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516162054?lang=zh_cn&edition=full","pubTime":"2025-03-04 19:55","pubTimestamp":1741089323,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Neumora Therapeutics(NMRA.US)评级，由买入调整至买入评级, 目标价由30.00美元调整至18.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04195548519788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177838069","title":"Neumora Therapeutics 2024年第四季度GAAP每股收益$(0.37)，优于预期的$(0.45)，现金余额为3.076亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177838069","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177838069?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:18","pubTimestamp":1741004329,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics(LENZ) 2024年第四季度GAAP每股收益$(0.37)，优于预期的$(0.45)，现金余额为3.076亿美元以上内容来自Benzinga Earnings专栏，原文如下：Neumora $Therapeutics(LENZ)$ Q4 2024 GAAP EPS $(0.37) Beats $(0.45) Estimate, Cash Balance Of $307.6M","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512859654","title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512859654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512859654?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:56","pubTimestamp":1739976980,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时56分，Neumora Therapeutics, Inc.股票出现异动，股价大幅下跌5.20%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225620a24bffeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225620a24bffeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NMRA","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511213325","title":"Neumora Therapeutics, Inc.盘中异动 早盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511213325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511213325?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:23","pubTimestamp":1739460231,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时23分，Neumora Therapeutics, Inc.股票出现波动，股价快速跳水5.00%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213232351a244b6ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213232351a244b6ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509493522","title":"Neumora Therapeutics, Inc.盘中异动 下午盘快速上涨5.11%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509493522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509493522?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:05","pubTimestamp":1738695957,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时05分，Neumora Therapeutics, Inc.股票出现异动，股价急速拉升5.11%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205030557961801c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205030557961801c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508144364","title":"Neumora Therapeutics, Inc.盘中异动 股价大跌5.15%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508144364?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:03","pubTimestamp":1738594983,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时03分，Neumora Therapeutics, Inc.股票出现波动，股价急速下跌5.15%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230303abc10e72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230303abc10e72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505179270","title":"Neumora Therapeutics, Inc.盘中异动 股价大跌5.29%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505179270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505179270?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:27","pubTimestamp":1737646057,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时27分，Neumora Therapeutics, Inc.股票出现波动，股价大幅跳水5.29%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123232738960e5015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123232738960e5015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501773593","title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大跌6.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501773593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501773593?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:30","pubTimestamp":1736346655,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时30分，Neumora Therapeutics, Inc.股票出现异动，股价快速下挫6.59%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223055a21a523f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223055a21a523f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501008362","title":"Neumora Therapeutics, Inc.盘中异动 早盘大幅上涨7.66%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501008362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501008362?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:32","pubTimestamp":1736260355,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时32分，Neumora Therapeutics, Inc.股票出现波动，股价快速拉升7.66%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223235a218e75c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223235a218e75c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501253945","title":"Neumora Therapeutics, Inc.盘中异动 急速拉升6.91%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501253945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501253945?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:35","pubTimestamp":1736174115,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时35分，Neumora Therapeutics, Inc.股票出现波动，股价急速上涨6.91%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223515a2179737&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223515a2179737&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501388082","title":"B of A Securities：维持Neumora Therapeutics(NMRA.US)评级，由买入调整至买入评级, 目标价由22.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501388082","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501388082?lang=zh_cn&edition=full","pubTime":"2025-01-06 19:51","pubTimestamp":1736164291,"startTime":"0","endTime":"0","summary":"B of A Securities：维持Neumora Therapeutics(NMRA.US)评级，由买入调整至买入评级, 目标价由22.00美元调整至7.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/06195147168585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500111002","title":"Neumora Therapeutics, Inc.股价拉升12.57% 市值涨4503.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500111002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500111002?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:31","pubTimestamp":1735914719,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分，Neumora Therapeutics, Inc.股票出现波动，股价大幅上涨12.57%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223159a21468e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123859302","title":"医药股Neumora重磅失利！抗忧郁疗法临床试验未达标，股价暴跌引市场关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1123859302","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123859302?lang=zh_cn&edition=full","pubTime":"2025-01-03 08:34","pubTimestamp":1735864446,"startTime":"0","endTime":"0","summary":"$Neumora Therapeutics, Inc.$ 的主要抗忧郁药物navacaprant在第三期KOASTAL-1研究中未能达成预期目标，导致股价周四大跌81.42%。Neumora Therapeutics于周四宣布，其针对主要忧郁症的Phase 3 KOASTAL-1临床试验结果不尽如人意，未能达成主要终点。然而，最新的试验资料显示，这款药物并未有效改善受试者的病情，令市场信心受到重创。根据分析师的评估，此次失败可能会影响Neumora未来的研发计划与资金运作。未来，Neumora需要重新评估其产品线及策略，以应对当前困境，并寻找其他潜在的成功路径。","market":"us","thumbnail":"https://static.tigerbbs.com/3299f0aa430f44d45729a266d0f7b350","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3299f0aa430f44d45729a266d0f7b350"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"医药股Neumora重磅失利！抗忧郁疗法临床试验未达标，股价暴跌引市场关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.neumoratx.com","stockEarnings":[{"period":"1week","weight":-0.1478},{"period":"1month","weight":0.2099},{"period":"3month","weight":-0.7319},{"period":"6month","weight":-0.7669},{"period":"1year","weight":-0.8406},{"period":"ytd","weight":-0.7604}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neumora Therapeutics, Inc.最初于2019年11月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，旨在通过提出下一代脑渗透化学新疗法，为患者提供更好的治疗结果和生活质量，以应对其这一代人面临的最大医疗挑战。该公司的治疗管道目前包括针对各种服务不足的流行疾病的新作用机制的项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.277431},{"month":2,"riseRate":0.666667,"avgChangeRate":0.248427},{"month":3,"riseRate":0,"avgChangeRate":-0.340105},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.097481},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.081111},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.021473},{"month":7,"riseRate":0.666667,"avgChangeRate":0.642716},{"month":8,"riseRate":0,"avgChangeRate":-0.132338},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.117003},{"month":10,"riseRate":0.25,"avgChangeRate":-0.021018},{"month":11,"riseRate":0.5,"avgChangeRate":-0.025083},{"month":12,"riseRate":0.666667,"avgChangeRate":0.085781}],"exchange":"NASDAQ","name":"Neumora Therapeutics, Inc.","nameEN":"Neumora Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neumora Therapeutics, Inc.,NMRA,Neumora Therapeutics, Inc.股票,Neumora Therapeutics, Inc.股票老虎,Neumora Therapeutics, Inc.股票老虎国际,Neumora Therapeutics, Inc.行情,Neumora Therapeutics, Inc.股票行情,Neumora Therapeutics, Inc.股价,Neumora Therapeutics, Inc.股市,Neumora Therapeutics, Inc.股票价格,Neumora Therapeutics, Inc.股票交易,Neumora Therapeutics, Inc.股票购买,Neumora Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}